Hypogammaglobulinemia
Pipeline by Development Stage
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (6)
Total enrollment: 842 patients across 6 trials
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients
Post-bypass Prophylactic IVIG in Infants and Neonates
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.